# EpimAB funding: rounds and investors

> EpimAB has raised $25M across 1 round since 2017. Investors include 3E Bioventures and Oriza Seed Capital/ Decheng Capital. Every round with its source.

Source: https://millionrounds.com/company/epimab (Millionrounds; every figure on the page links to its filing or article)

China · [Series A startup](https://millionrounds.com/companies)

# Who invested in *EpimAB*

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$25M** raised across 1 round since 2017, from 1 source

- **Latest round:** Series A, $25M Apr 2017
- **Investors:** 2

See who backed them

## The rounds

- **Apr 2017** Series A **$25M** [3E Bioventures](https://millionrounds.com/fund/3e-bioventures) Oriza Seed Capital/ Decheng Capital Reported by FinSMEs

## Everyone who backed them

[3E Bioventures](https://millionrounds.com/fund/3e-bioventures) VC firm **1** round

Oriza Seed Capital/ Decheng Capital no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=epimab).

## Quick answers about EpimAB

### Who invested in EpimAB?

EpimAB's investors include 3E Bioventures and Oriza Seed Capital/ Decheng Capital.

### How much has EpimAB raised?

EpimAB has raised $25M across 1 round since 2017.

### When did EpimAB last raise?

EpimAB's most recent round was a Series A of $25M in Apr 2017.

### What was EpimAB's biggest round?

Its most recent round, $25M in Apr 2017, is also its largest on record.

### Who backed EpimAB first?

EpimAB's first round on record, in Apr 2017, was backed by 3E Bioventures and Oriza Seed Capital/ Decheng Capital.

### What stage is EpimAB at?

EpimAB's latest named round is a Series A, in Apr 2017.

### Where is EpimAB based?

EpimAB is based in China.

## Companies like EpimAB

In the same sector, and raised in the last eighteen months.

[**Nutshell Therapeutics** $40M · Sept 2026](https://millionrounds.com/company/nutshell-therapeutics)[**RNAimmune** $4.5M · Aug 2026](https://millionrounds.com/company/rnaimmune)[**Gestala** $22M · Mar 2026](https://millionrounds.com/company/gestala)[**Adlai Nortye** $190M · Feb 2026](https://millionrounds.com/company/adlai-nortye)[**HitGen** $39M · Nov 2025](https://millionrounds.com/company/hitgen)[**Adagene** $83M · Jul 2025](https://millionrounds.com/company/adagene)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app